Drug Shortage Report for CHLORDIAZEPOXIDE
| Report ID | 202731 |
| Drug Identification Number | 00522996 |
| Brand name | CHLORDIAZEPOXIDE |
| Common or Proper name | Chlordiazepoxide |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CHLORDIAZEPOXIDE HYDROCHLORIDE |
| Strength(s) | 25MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 BTL |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | |
| Actual start date | 2023-08-15 |
| Estimated end date | |
| Actual end date | 2023-09-13 |
| Shortage status | Resolved |
| Updated date | 2023-09-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-09-14 | English | Compare |
| v4 | 2023-09-13 | French | Compare |
| v3 | 2023-09-13 | English | Compare |
| v2 | 2023-08-23 | French | Compare |
| v1 | 2023-08-23 | English | Compare |
Showing 1 to 5 of 5